Back to Search
Start Over
Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease: European Atherosclerosis Society/European Society of Vascular Medicine Joint Statement
- Publication Year :
- 2021
- Publisher :
- Elsevier, 2021.
-
Abstract
- Patients with peripheral arterial disease (PAD) are at very high risk of cardiovascular events, but risk factor management is usually suboptimal. This Joint Task Force from the European Atherosclerosis Society and the European Society of Vascular Medicine has updated evidence on the management on dyslipidaemia and thrombotic factors in patients with PAD. Guidelines recommend a low-density lipoprotein cholesterol (LDLC) goal of more than 50% reduction from baseline and
- Subjects :
- 610 Medicine & health
Subjects
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi...........dfee3c62f0cc1e5563aec64fcdd7982d
- Full Text :
- https://doi.org/10.48350/162955